McLeod Cancer and Blood Center

Johnson City, Tennessee 37604

0 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chemotherapy Side Effects, Fatigue, Lung Cancer, Metastatic Breast Cancer, Myelodysplastic Syndromes, Neoplasms, Lung, Neoplasms, Pulmonary, Prostate Cancer

Studies at this site

• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer — Completed
• Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes — Completed
• Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents — Stopped early
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early
• Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy — Stopped early